Chinese Journal of New Drugs Articles

Articles>Articles Overview

1Outline of New Drug Administrative Licensing System in China 721-723

2Progress of new drugs in anti-tumor invasion and metastasis 727-732

3Breakthrough drug for chronic myeloid leukemia, imatinib 732-735

4Recent advances of research on recombinant human interleukin-11 735-738

5Actuality of pre-and post-operation chemotherapy for NSCLC 738-743

6The application of topotecan in treatment of small cell lung cancer(SCLC)743-746

7Antitumor effect of ZXH951, a novel progesterone receptor antagonist,on hormone dependent mouse MXT mammary transplantable tumor 747-749

8Study on the effect of boanmycin against human-hepatoma BEL-7402 cells and its mechanism in molecular level 749-752

9Clinical pharmacokinetics of recombinant human necrosis factor-α mutant rhTNFαD11a753-755

10Study of the blood concentration of MTX in the treatment of children leukemia 755-757

11Clinical trial of domestic doxifluridine(5'-DFUR)capsule in treatment of malignancies 758-760

12Phase Ⅱ clinical trial of domestic TPT(topotecan) hydrochloride 760-763

13Clinical study of letrozole in the treatment of postmenopausal women with advanced breast cancer(ABC)763-766

14Clinical study of the efficacy and safety of lornoxicam in treatment of spondyloarthropathy 766-768

15Evaluation the analgesic effect of compound capsule of oxycodone and acetaminophen 768-771

16Monitoring the bacterial sensitivity to antibiotics in elderly patients with lower respiratory tract infections 780-782